Elligint Health, Inc.

Founded in 2024 and based in New Jersey, US, Elligint Health, Inc. specializes in intelligent healthcare solutions aimed at enhancing healthcare delivery for providers, payers, and patients through integrated data intelligence. In December 2024, Elligint Health raised USD 3. 2 million in venture funding from various investors.

Elligint Health's primary offerings center around intelligent healthcare solutions designed to streamline and enhance care delivery for providers, payers, and patients. The company focuses on integrating diverse data sources to provide actionable intelligence, thereby empowering users to engage in proactive, whole-person care. Their products are tailored to simplify complexities in healthcare, ultimately improving outcomes and facilitating better decision-making. Elligint Health serves a broad client base that spans multiple sectors within the healthcare ecosystem, including hospitals, health systems, insurance companies, and individual patients.

  Elligint Health's revenue model is structured around partnerships and subscription-based services, with clients engaging in long-term relationships that foster ongoing support and product enhancements. The company primarily generates revenue through B2B transactions, where healthcare organizations subscribe to their intelligent health solutions.   The December 2024 funding will support the development of new products aimed at addressing specific needs within the healthcare market. The company is planning to expand into additional North American regions, with further details on specific target markets expected to be announced in 2025.

Through this growth strategy, Elligint Health aims to utilize its recent funding to enhance its product offerings and scale its operations effectively.